Blog
RSS FeedPosted by Michael Wonder on 17 Jun 2018
Drug patents could be Canada's special weapon in U.S. trade dispute
16 June 2018 - Taking an 'asymmetrical' approach and targeting U.S. intellectual property has worked in the past, experts say. ...
Posted by Michael Wonder on 16 Jun 2018
Rare disease therapy Crysvita to be barred from NHS
15 June 2018 - Children and young people with X-linked hypophosphataemia are unlikely to get routine access to Kyowa Kirin’s ...
Posted by Michael Wonder on 16 Jun 2018
Adding pertuzumab to existing treatments after surgery for early breast cancer not cost effective, says NICE in draft guidance
15 June 2018 - Women with a type of early breast cancer may not benefit from continuing or starting a ...
Posted by Michael Wonder on 14 Jun 2018
ALP 2% health insurance premium cap to hit margins
14 June 2018 - Bill Shorten’s plan to freeze health insurance premium increases at 2% will add pressure to insurers’ ...
Posted by Michael Wonder on 14 Jun 2018
Health care system performs well, but faces challenges
14 June 2018 - The latest snapshot of the quality of New Zealand’s health care shows a health system that ...
Posted by Michael Wonder on 14 Jun 2018
From EpiPens to antibiotics, report finds Canada's drug shortages could be getting worse
13 June 2018 - Researchers find 1 in 10 drugs sold in Canada are back-ordered or discontinued. ...
Posted by Michael Wonder on 14 Jun 2018
Building synergy between regulatory and HTA agencies beyond processes and procedures—can we effectively align the evidentiary requirements? A survey of stakeholder perceptions
13 June 2018 - The pathway for bringing a new medicine to the market is dependent on two sequential processes: achieving ...
Posted by Michael Wonder on 14 Jun 2018
Effect of cross-over in oncology clinical trials on evidence levels in early benefit assessment in Germany
13 June 2018 - In oncology clinical trials, cross-over is used frequently but may lead to uncertainties regarding treatment effects. ...
Posted by Michael Wonder on 13 Jun 2018
Metastatic breast cancer: highly selective post-hoc analysis rather than complete publication of quality of life data
13 June 2018 - IQWiG employees criticise the publication practice of PALOMA-2 study authors. ...
Posted by Michael Wonder on 13 Jun 2018
Janssen’s Tremfya (guselkumab) receives its first two positive Health Technology Assessments in Europe
13 June 2018 - The United Kingdom’s NICE publishes positive guidance for the first selective interleukin 23 inhibitor to treat moderate ...
Posted by Michael Wonder on 13 Jun 2018
Drug approved for leukaemia treatment
11 June 2018 - A drug that reduces the chances of relapse for people with an aggressive type of leukaemia ...
Posted by Michael Wonder on 13 Jun 2018
Public backs NHS spending increases
13 June 2018 - An “overwhelming majority” of people support increasing spending on health and social care services, indicates a ...
Posted by Michael Wonder on 13 Jun 2018
Digital health to transform Australia’s health system and save lives
13 June 2018 - Australia now has many of the building blocks in place to roll out a digitally enabled ...
Posted by Michael Wonder on 12 Jun 2018
85% of Canadians now have publicly funded access to a potentially life-extending treatment for patients with rare lung disease
12 June 2018 - Patients living in Alberta, Saskatchewan, Manitoba, Ontario and Newfoundland and Labrador are hopeful Uptravi will soon be ...
Posted by Michael Wonder on 12 Jun 2018
SMC approves funding for six new therapies on the NHS
12 June 2018 - The Scottish Medicines Consortium has approved NHS funding for six new therapies, offering patients new options ...